Dianthus Therapeutics | MGTA - Vermögenswerte

Aktienkurs
87.39
Täglich Wechseln
-2.43 -2.71%
Monatlich
9.77%
Jährlich
303.28%
Q2 Prognose
85.52




Vermögenswerte Veränderung Datum
Akebia Therapeutics USD 376.56M 12.41M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Avita Medical AUD 56.39M 1.74M 2025-12
Celltrion KRW 21.08T 530.63B 2025-09
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
IQVIA Holdings USD 29.94B 1.22B 2025-12
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Moderna USD 12.34B 203M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 530.67M 31.54M 2025-12
Organon & Co USD 13.55B 52M 2025-09
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pharma Mar EUR 395.08M 53.42M 2025-12
Qiagen NV USD 6.3B 257.54M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Sartorius EUR 9.87B 154.9M 2026-03
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tectonic Therapeutic USD 261.04M 15.96M 2025-12
Tilray USD 2.1B 15.95M 2025-09
Viatris USD 37.19B 727.3M 2025-12
Xeris Pharmaceuticals USD 383.53M 13.34M 2025-12
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 17.48B 1.23B 2025-09